CLINICAL ROLE -
Prevention of Infective Endocarditis: An Update
health-systems PRODUCT news
Colorectal Cancer: A New Paradigm
Do You Need an NPI Number?
WOMEN MAY NOT BENEFIT FROM ASPIRIN THERAPY
Compulsory Licensing: A Necessary Evil?
generic times product news
GENERIC BOOM FORECAST FOR 2011-2012
INDIAN FIRMS MUSCLING IN ON US MARKET
LEADERS PRESSURE CMS ON ANTI?GENERIC RULES
GOVERNORS PUSH CONGRESS TO ACT ON BIOGENERICS
COURT OPENS DOOR FOR MORE PATENT CASES
DEALS DELAYING GENERIC ENTRY DRAW FIRE
CURBS ON GENERIC INHALERS WILL COST AMERICANS $1.4 BILLION
FDA DESIGNATES "CRITICAL PATH" FOR APPROVING NEW GENERICS
Symptoms of Heart Failure May Be Relieved by Tolvaptan
CYPHER Stent Continues to Prove Its Worth
Traveler's Diarrhea Relieved by Single Dose of Zithromax
Drug Therapy as Effective as Stents for Stable Heart Disease
Investigational Drug Controls BP
HPV Vaccine Is the Latest Weapon Against Cancer
Elan and Biogen Idec's Tysabri
AstraZeneca's Seroquel
rx PRODUCT news
GlaxoSmithKline Consumer Healthcare's alli
Premenstrual Syndrome Products
Multivitamin Supplements for Women
Calcium
PHARMACY COMPETITION IS STIFF FOR URBAN INDEPENDENTS, STUDY FINDS
When Will Biogenerics Be Available?
